Illuminating the dark side of neuraminidase in influenza immunity

Illuminating the dark side of neuraminidase in influenza immunity

The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "univers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Immunity (Cambridge, Mass.) Mass.), 2023-11, Vol.56 (11), p.2463-2465
1. Verfasser: Ippolito, Gregory C.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2465
container_issue 11
container_start_page 2463
container_title Immunity (Cambridge, Mass.)
container_volume 56
creator Ippolito, Gregory C.
description The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.
doi_str_mv 10.1016/j.immuni.2023.10.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2890758452</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2890758452</sourcerecordid><originalsourceid>FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</originalsourceid><addsrcrecordid>eNotkE1PwzAMhiMEEmPwDzjkyKXFidM2PU4TH5MmcYFzlDUJZLTpSNrD-PW0KpItW69f2dZDyD2DnAErH4-577ox-JwDx0nKgfELsmJQV5lgEi7nvhJZVTK8JjcpHQGYKGpYkc2ubcfOBz348EmHL0uNjt80eWNp72iwY9TT2BudLPVhCteONvxqupwczrfkyuk22bv_uiYfz0_v29ds__ay2272WcMRh8xYJ4Scs2HFgUPBSjSWS5CIXDiD0kks3MExzi0gr0vUEoUwrm4O2Ehck4dl7yn2P6NNg-p8amzb6mD7MSkua6gKKQo-WcVibWKfUrROnaLvdDwrBmompo5qeV_NxGZ1IoZ_GkxgyQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2890758452</pqid></control><display><type>article</type><title>Illuminating the dark side of neuraminidase in influenza immunity</title><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ippolito, Gregory C.</creator><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><description>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</description><identifier>ISSN: 1074-7613</identifier><identifier>EISSN: 1097-4180</identifier><identifier>DOI: 10.1016/j.immuni.2023.10.012</identifier><language>eng</language><ispartof>Immunity (Cambridge, Mass.), 2023-11, Vol.56 (11), p.2463-2465</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</cites><orcidid>0000-0002-7565-7002</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27931,27932</link.rule.ids></links><search><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><title>Illuminating the dark side of neuraminidase in influenza immunity</title><title>Immunity (Cambridge, Mass.)</title><description>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</description><issn>1074-7613</issn><issn>1097-4180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNotkE1PwzAMhiMEEmPwDzjkyKXFidM2PU4TH5MmcYFzlDUJZLTpSNrD-PW0KpItW69f2dZDyD2DnAErH4-577ox-JwDx0nKgfELsmJQV5lgEi7nvhJZVTK8JjcpHQGYKGpYkc2ubcfOBz348EmHL0uNjt80eWNp72iwY9TT2BudLPVhCteONvxqupwczrfkyuk22bv_uiYfz0_v29ds__ay2272WcMRh8xYJ4Scs2HFgUPBSjSWS5CIXDiD0kks3MExzi0gr0vUEoUwrm4O2Ehck4dl7yn2P6NNg-p8amzb6mD7MSkua6gKKQo-WcVibWKfUrROnaLvdDwrBmompo5qeV_NxGZ1IoZ_GkxgyQ</recordid><startdate>20231114</startdate><enddate>20231114</enddate><creator>Ippolito, Gregory C.</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7565-7002</orcidid></search><sort><creationdate>20231114</creationdate><title>Illuminating the dark side of neuraminidase in influenza immunity</title><author>Ippolito, Gregory C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c233t-def448f448c15b205163de28083324fd38f835fbf122e032963a8344df9cb3c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ippolito, Gregory C.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Immunity (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ippolito, Gregory C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Illuminating the dark side of neuraminidase in influenza immunity</atitle><jtitle>Immunity (Cambridge, Mass.)</jtitle><date>2023-11-14</date><risdate>2023</risdate><volume>56</volume><issue>11</issue><spage>2463</spage><epage>2465</epage><pages>2463-2465</pages><issn>1074-7613</issn><eissn>1097-4180</eissn><abstract>The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.</abstract><doi>10.1016/j.immuni.2023.10.012</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-7565-7002</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1074-7613
ispartof Immunity (Cambridge, Mass.), 2023-11, Vol.56 (11), p.2463-2465
issn 1074-7613
1097-4180
language eng
recordid cdi_proquest_miscellaneous_2890758452
source Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier)
title Illuminating the dark side of neuraminidase in influenza immunity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-08T00%3A34%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Illuminating%20the%20dark%20side%20of%20neuraminidase%20in%20influenza%20immunity&rft.jtitle=Immunity%20(Cambridge,%20Mass.)&rft.au=Ippolito,%20Gregory%20C.&rft.date=2023-11-14&rft.volume=56&rft.issue=11&rft.spage=2463&rft.epage=2465&rft.pages=2463-2465&rft.issn=1074-7613&rft.eissn=1097-4180&rft_id=info:doi/10.1016/j.immuni.2023.10.012&rft_dat=%3Cproquest_cross%3E2890758452%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2890758452&rft_id=info:pmid/&rfr_iscdi=true